Literature DB >> 12414769

Antimicrobial susceptibilities and serotype distribution of Streptococcus pneumoniae isolates from a Low socioeconomic area in Lima, Peru.

Anna R Cullotta1, H D Kalter, Jose Delgado, Robert H Gilman, Richard R Facklam, Billie Velapatino, Jorge Coronel, Lilia Cabrera, M Urbina.   

Abstract

Streptococcus pneumoniae isolates were obtained from nasopharyngeal swabs taken from children living in a low socioeconomic area of Lima, Peru, to determine the rates of antimicrobial resistance and serotype distribution. A total of 146 nasopharyngeal isolates were collected from children from 3 to 38 months of age. Twenty-one clinical laboratory isolates from both sterile and nonsterile sites were obtained from a local hospital. Isolates with reduced susceptibilities to penicillin represented 15.1 and 42.9% of the nasopharyngeal and clinical isolates, respectively. For neither group of isolates did penicillin MICs exceed 1.5 micro g/ml, indicating only intermediate resistance. Thirty-two different serotypes were identified from the 146 nasopharyngeal isolates. The serotypes of the clinical isolates were represented among those 32 types. Isolates with reduced susceptibility to multiple antimicrobial agents were present in both settings. These findings indicate some of the highest rates of antimicrobial resistance in the region as well as a slightly different serotype distribution pattern from those of other South American countries. The 7-valent conjugate pneumococcal vaccines would only have a limited effect, providing coverage for about half of all isolates. Increasing rates of resistance in Peru necessitate an awareness of antimicrobial treatment practices and vaccination strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12414769      PMCID: PMC130113          DOI: 10.1128/cdli.9.6.1328-1331.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  13 in total

Review 1.  Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae.

Authors:  J L di Fabio; A Homma; C de Quadros
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

2.  Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City.

Authors:  G Echániz-Aviles; M E Velázquez-Meza; M N Carnalla-Barajas; A Soto-Noguerón; F Solórzano-Santos; A Pérez Miravete; R Gatica-Marquina; J L di Fabio
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

3.  Prevalence of serotypes and antimicrobial resistance of streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America.

Authors:  M C Brandileone; V S Vieira; S T Casagrande; R C Zanella; M L Guerra; S Bokermann; J C De Moraes; E R Baldacci; C B Chamone; M A Oliveira; D G De Matos; T M Arruda; M F Coelho; S M D'Avila; A R Dos Santos; J L Di Fabio
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

4.  Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Pneumococcal Study Group in Colombia.

Authors:  E Castañeda; A L Leal; O Castillo; F De La Hoz; M C Vela; M Arango; H Trujillo; A Levy; M E Gama; M Calle; M L Valencia; W Parra; N Agudelo; G I Mejía; S Jaramillo; F Montoya; H Porras; A Sánchez; D Saa; J L Di Fabio; A Homma
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

5.  Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Streptococcus pneumoniae Working Group.

Authors:  A Rossi; R Ruvinsky; M Regueira; A Corso; J Pace; A Gentile; J L Di Fabio
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

6.  The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

Authors:  W P Hausdorff; J Bryant; C Kloek; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

7.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

9.  Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile.

Authors:  G Gherardi; J S Inostrozo; M O'Ryan; V Prado; S Prieto; C Arellano; R R Facklam; B Beall
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

10.  Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization.

Authors:  A Tomasz; A Corso; E P Severina; G Echániz-Aviles; M C Brandileone; T Camou; E Castañeda; O Figueroa; A Rossi; J L Di Fabio
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

View more
  3 in total

1.  Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

Authors:  B Quintero; M Araque; C van der Gaast-de Jongh; F Escalona; M Correa; S Morillo-Puente; S Vielma; P W M Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-30       Impact factor: 3.267

Review 2.  Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Authors:  Elizabeth Castañeda; Clara Inés Agudelo; Rodrigo De Antonio; Diego Rosselli; Claudia Calderón; Eduardo Ortega-Barria; Rómulo E Colindres
Journal:  BMC Infect Dis       Date:  2012-05-28       Impact factor: 3.090

3.  Analysing pneumococcal invasiveness using Bayesian models of pathogen progression rates.

Authors:  Alessandra Løchen; James E Truscott; Nicholas J Croucher
Journal:  PLoS Comput Biol       Date:  2022-02-17       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.